These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25635421)

  • 21. The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients.
    Maas RPPWM; Killaars S; van de Warrenburg BPC; Schutter DJLG
    J Neurol; 2021 Sep; 268(9):3456-3466. PubMed ID: 33743045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression and clinical progression in spinocerebellar ataxias.
    Lo RY; Figueroa KP; Pulst SM; Perlman S; Wilmot G; Gomez C; Schmahmann J; Paulson H; Shakkottai VG; Ying S; Zesiewicz T; Bushara K; Geschwind M; Xia G; Yu JT; Lee LE; Ashizawa T; Subramony SH; Kuo SH
    Parkinsonism Relat Disord; 2016 Jan; 22():87-92. PubMed ID: 26644294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the clinical meaningfulness of the Scale for the Assessment and Rating of Ataxia: A comparison of patient and physician perspectives at the item level.
    Maas RPPWM; van de Warrenburg BPC
    Parkinsonism Relat Disord; 2021 Oct; 91():37-41. PubMed ID: 34479057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological evaluation of spinocerebellar ataxias 1, 2 and 3.
    Yadav R; Pal PK; Krishna N; Amar BR; Jain S; Purushottam M
    J Neurol Sci; 2012 Jan; 312(1-2):142-5. PubMed ID: 21880333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [SCA1, SCA2, MJD/SCA3 (CAG)n mutation detection and analysis in patients with hereditary spinocerebellar ataxia from Chinese families].
    Tang B; Wang D; Xia J
    Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):819-22. PubMed ID: 9772474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occupational therapy in spinocerebellar ataxia type 3: an open-label trial.
    Silva RC; Saute JA; Silva AC; Coutinho AC; Saraiva-Pereira ML; Jardim LB
    Braz J Med Biol Res; 2010 Jun; 43(6):537-42. PubMed ID: 20414586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease.
    Matilla T; McCall A; Subramony SH; Zoghbi HY
    Ann Neurol; 1995 Jul; 38(1):68-72. PubMed ID: 7611728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in the cortical complexity of spinocerebellar ataxia type 3 appears earlier than clinical symptoms.
    Wang TY; Jao CW; Soong BW; Wu HM; Shyu KK; Wang PS; Wu YT
    PLoS One; 2015; 10(4):e0118828. PubMed ID: 25897782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
    Chou AH; Chen YL; Chiu CC; Yuan SJ; Weng YH; Yeh TH; Lin YL; Fang JM; Wang HL
    Neuropharmacology; 2015 Dec; 99():308-17. PubMed ID: 26254860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.
    Dürr A; Stevanin G; Cancel G; Duyckaerts C; Abbas N; Didierjean O; Chneiweiss H; Benomar A; Lyon-Caen O; Julien J; Serdaru M; Penet C; Agid Y; Brice A
    Ann Neurol; 1996 Apr; 39(4):490-9. PubMed ID: 8619527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six cases of SCA3/MJD patients that mimic hereditary spastic paraplegia in clinic.
    Wang YG; Du J; Wang JL; Chen J; Chen C; Luo YY; Xiao ZQ; Jiang H; Yan XX; Xia K; Pan Q; Tang BS; Shen L
    J Neurol Sci; 2009 Oct; 285(1-2):121-4. PubMed ID: 19608203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease.
    Cancel G; Gourfinkel-An I; Stevanin G; Didierjean O; Abbas N; Hirsch E; Agid Y; Brice A
    Hum Mutat; 1998; 11(1):23-7. PubMed ID: 9450899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled pilot trial of game-based training in individuals with spinocerebellar ataxia type 3.
    Wang RY; Huang FY; Soong BW; Huang SF; Yang YR
    Sci Rep; 2018 May; 8(1):7816. PubMed ID: 29777115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3.
    Chou AH; Chen SY; Yeh TH; Weng YH; Wang HL
    Neurobiol Dis; 2011 Feb; 41(2):481-8. PubMed ID: 21047555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized double-blind placebo-controlled trial of the effects of oral trehalose in spinocerebellar ataxia type 3: An interim analysis.
    Yap KH; Azmin S; Abdul Manan H; Yahya N; Ahmad N; Tajurudin FW; Mat Desa SH; van de Warrenburg B; Mohamed Mukari SA; Achok HN; Ahmad Damanhuri H; Rani R; Mohamed Ibrahim N
    Parkinsonism Relat Disord; 2024 Jul; 124():107013. PubMed ID: 38843619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis and application of SCA1 and SCA3/MJD gene CAG repeats in Han population in Northeastern China].
    Jiang M; Jin CL; Lin CK; Qiu GR; Liu ZL; Wang CX; Sun KL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):83-5. PubMed ID: 14767919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
    Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
    J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal neurophysiological study of SCA2 and SCA3 autosomal dominant hereditary spinocerebellar ataxias.
    Álvarez-Paradelo S; García A; Infante J; Berciano J
    Neurologia; 2011 Apr; 26(3):157-65. PubMed ID: 21163215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.